If you enjoyed Part 1 of David Epstein’s BJSM podcast listen to this one to hear about the genetic contribution to hypertrophic cardiomyopathy, the reason it is so hard to detect in all cases, and real life choices that some players made when offered genetic screening opportunities. We finish by discussing whether an Olympic cross-country ski champion with a hematocrit of 65 is a blood-doper or the carrier of an unusual single-gene mutation.
I learned a great deal from David Epstein in both podcasts; David has put the bar very high for future podcast guests.
Recorded at the Summit – Leaders in Performance – New York (June 17/18 2014); with permission from Leaders (James Worrall).
David Epstein’s session at Leaders was sponsored by Aspetar Orthopedic and Sports Medicine Hospital, Doha, Qatar.
For more related content:
Sports Cardiology module on BMJ Learning including Seattle Criteria: bit.ly/1lI8djo
J Drezner, M Ackerman, J Anderson et al, Electrocardiographic interpretation